Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets

Biochemical Pharmacology
Deena WaddletonJoseph A Mancini

Abstract

cAMP is a key modulator for glucose-dependent insulin secretion (GDIS). Members of the phosphodiesterase (PDEs) gene family regulate intracellular levels of cAMP by hydrolyzing cAMP to the corresponding inactive 5'AMP derivative. These studies examined the expression and function of all 18 cAMP-specific PDEs in the rat insulinoma derived INS-1 (832/13) cell and isolated rat islets using quantitative PCR and siRNA-mediated gene-specific knockdown. PDE1C, PDE3B, PDE4C, PDE8B, PDE10A, and PDE11A were significantly expressed in rat islets and INS-1 (832/13) cells at the mRNA level. PDE1C, PDE10A and PDE11A were also expressed in brain, along with PDE3B, PDE4C and PDE8B which were also highly expressed in liver, and PDE3B was present in adipose tissue and PDE4C in skeletal muscle. siRNA mediated knockdown of PDE1C, PDE3B, PDE8B and PDE4C, but not PDE10A and PDE11A, significantly enhanced GDIS in rat INS-1 (832/13) cells. Also, selective inhibitors of PDE3 (trequinsin) and PDE4 (roflumilast and L-826,141) significantly augmented GDIS in both INS-1 (832/13) cells and rat islets. The combination of PDE3 and PDE4 selective inhibitors demonstrate that these enzymes comprise a significant proportion of the cAMP metabolizing activity in IN...Continue Reading

References

Jan 1, 1995·Diabetes·M D LeibowitzP T Zafian
Jan 1, 1997·Annual Review of Biochemistry·M Montminy
Jun 1, 2000·Biochemistry·F LalibertéZ Huang
Aug 9, 2003·Diabetologia·N J Pyne, B L Furman
Nov 9, 2005·Atherosclerosis. Supplements·William R Hiatt
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Sep 14, 2006·Pharmacological Reviews·Andrew T Bender, Joseph A Beavo
Dec 16, 2006·Current Medicinal Chemistry·Zheng Huang, Joseph A Mancini
Apr 5, 2007·Current Medical Research and Opinion·Allison Cohen, Edward S Horton

❮ Previous
Next ❯

Citations

Feb 22, 2011·Archivos de bronconeumología·Julio Cortijo Gimeno, Esteban Morcillo Sánchez
Mar 1, 2010·Therapeutic Advances in Chronic Disease·Nicola J Sinden, Robert A Stockley
May 24, 2011·European Journal of Endocrinology·Delphine Vezzosi, Jérôme Bertherat
Oct 10, 2014·The Journal of Endocrinology·Michael RouseJosephine M Egan
Aug 14, 2012·Trends in Cell Biology·Jay H ChungJason R B Dyck
Oct 25, 2011·Current Opinion in Pharmacology·Claire Lugnier
Jan 25, 2011·Pulmonary Pharmacology & Therapeutics·Zuzana Diamant, Domenico Spina
Sep 14, 2012·Upsala Journal of Medical Sciences·Anders Tengholm
Jan 13, 2016·American Journal of Respiratory Cell and Molecular Biology·Hye Jung ParkJung-Won Park
Apr 9, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Antonia Alexandra EvripiotiMarcus Dorner
Aug 2, 2014·Molecular Endocrinology·Zhenshan ZhaoJustin P Annes
Dec 7, 2013·Endocrine Reviews·Monalisa F AzevedoConstantine A Stratakis
Aug 26, 2017·Scientific Reports·Fan Zhang, Emmanuel S Tzanakakis
Jun 27, 2019·Archives of Physiology and Biochemistry·Agnieszka Kilanowska, Tomasz Szkudelski
Jul 8, 2020·Proceedings of the National Academy of Sciences of the United States of America·Lien D NguyenBarbara E Ehrlich
Nov 7, 2020·International Journal of Molecular Sciences·Agnieszka Kilanowska, Agnieszka Ziółkowska
Jul 17, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abid BhatMeena Kishore Sakharkar
Apr 26, 2021·Pharmacology & Therapeutics·Arun SamiduraiRakesh C Kukreja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.